Targets and Receptors in the treatment of cancer

I would like to focus on the use of monoclonal antibodies and the tyrosine kinases inhibitors and then comparing them and their pros and cons in targeting the receptors of cancer cells?

Why they show promise for the treat ability of cancer and longevity of patients and their outcome with said novel therapies?

How effected are the monoclonal antibodies, Tyrosine kinase inhibitors?

Talking about both targets and the receptors and looking at how this allows personalized medicine. And how cost effect are the treatments? Also looking at how the treatments are administered via intravenous vs oral administration and which one is better.

Also, I work with British English.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>